Navigation Links
Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product
Date:11/10/2008

oles in cellular metabolism and signal transduction, the manipulation of which by several pharmaceuticals constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Duska is developing a portfolio of investigational medicines, two of which are in late stages of clinical testing. Duska's ATPace is expected to enter a pivotal Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia. Duska's CDP-1050 is expected to commence a Phase 2 clinical trial for the treatment of heart failure. In addition, Duska has a preclinical program in which it plans to develop new chemical entities that target a newly discovered pathway in the pathophysiology of chronic obstructive pulmonary disease. For more information, visit http://www.duskatherapeutics.com.

About DSM Pharmaceuticals, Inc.

DSM Pharmaceuticals, Inc., a business unit of DSM Pharmaceutical Products, is a global provider of custom manufacturing services to the pharmaceutical and biopharmaceutical industries. DSM's breadth of manufacturing services include the areas of steriles, orals and topicals, including dose form manufacturing, scheduled drugs, clinical manufacturing, fill finish manufacturing, and lyophilization services.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The forward-looking statements are based on current expectations, estimates and projections made by management. Duska intends for the forward- looking statements to be covered by the safe harbor provisions for forward- looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "es
'/>"/>

SOURCE Duska Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Duska Therapeutics Acquires Technology for ATPotent Sperm Motility Program
2. Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
3. Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
4. Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM)
5. Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2009 Financial Results on Monday, November 10th, at 4:30 P.M. EST
6. Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results
7. Cell Therapeutics, Inc. (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
8. Cornerstone Therapeutics Announces New Board of Directors
9. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
10. Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
11. Cell Therapeutics, Inc. (CTI) Oppenheimer & Co. Healthcare Conference Presentation to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 30, 2014 According to Bloomberg ... that requires Takeda Pharmaceutical Co. and Eli Lilly & ... claims that the drugmakers concealed information about a risk ... The case, Allen v. Takeda Pharmaceuticals North America Inc. ... District of Louisiana (Lafayette).* , According to Bloomberg, Takeda ...
(Date:8/30/2014)... 2014 United Theological Seminary is pleased to ... the Master of Theological Studies (MTS). , ... designed for students who wish to pursue further academic study ... to serve the Church and community. Previously, students needed to ... can attend classes from any location where there is an ...
(Date:8/30/2014)... August 30, 2014 Daily Gossip magazine ... keeps anxiety and panic attacks under control with a ... program review describes this new method as an ... panic attacks and overcome general anxiety related disorders. ... is the fact that it can be accessed by ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 RB SEO ... cost SEO service for small businesses. , RBSEO Services ... cannot afford costly search engine optimization service. So, the ... small businesses into account. , On being asked ... have introduced this low cost SEO service because many ...
(Date:8/30/2014)... a common problem millions of American cope with every day. While ... for some, it can have a crippling impact on social activity ... mood swings and depression. , Those struggling with acne are ... some cases, that can make the problem even worse. Instead of ... quest for clearer skin can now view acne treatment reviews ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2Health News:United Theological Seminary Announces First Fully Online Degree 2Health News:Panic Away Review Reveals New Natural Remedy for Anxiety Patients 2Health News:RBSEO Services Introduces Low Cost SEO Service for Small Businesses 2Health News:Acne Treatment Reviews Added to Popular Treatment Website 2
... ATLANTA The context in which adolescent sexual ... between sexual intercourse and education, according to research ... of the American Sociological Association. "Compared to ... often academically harmless, whereas in other types of ...
... HealthDay Reporter , WEDNESDAY, Aug. 11 (HealthDay ... brain stimulation appeared to improve memory slightly in several ... that the findings are very preliminary and that "no ... However, test results and brain imaging suggest that the ...
... Mott HealthDay Reporter , FRIDAY, Aug. 13 (HealthDay News) ... he found an empty bottle of ibuprofen on the living room ... puppy, Otis, had knocked the pain-reliever container off the coffee table ... devoured dozens of the pills. "My heart dropped through the ...
... HealthDay Reporter , THURSDAY, Aug. 12 (HealthDay News) ... jams and work deadlines may depend, in part, on how ... suggests. "The message is that father-son relationships are incredibly ... study lead author Melanie Mallers, an assistant professor at California ...
... 12, 2010) The American Society of ... scientific community and federal agencies to help propel ... make real strides in improving patient care. These ... scientific journal, in the article titled " Enhancing ...
... An elevated resting heart rate that develops or persists during ... whether from heart disease or other causes, researchers from the ... Center found studying outcomes in more than 9,000 patients. , ... 2 online in the European Heart Journal , suggest ...
Cached Medicine News:Health News:Sex between adolescents in romantic relationships is often harmless to their academics 2Health News:Deep Brain Stimulation Studied for Alzheimer's 2Health News:Deep Brain Stimulation Studied for Alzheimer's 3Health News:Human Meds Are Pets' Biggest Poisoning Danger 2Health News:Human Meds Are Pets' Biggest Poisoning Danger 3Health News:Bond With Dad May Play Role in Whether Men 'Stress Out' 2Health News:ASH recommends cross-disciplinary engagement to advance regenerative medicine 2Health News:Elevated heart rate over time linked to significant risk of death 2Health News:Elevated heart rate over time linked to significant risk of death 3
(Date:8/29/2014)... August 29, 2014 According ... Market by Extraction type (SFE, Cold Pressed, Organic ... Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - Global ... defines and segments the Amaranth Seed Oil Market ... size in terms of value. The Amaranth Seed ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Development Trend Forecast of Pharmaceutical Equipment Market in China, ... Research and Development Trend Forecast of Pharmaceutical Equipment Market ... China,s pharmaceutical equipment industry in ... competition landscape, and business performance of domestic major enterprises, ...
(Date:8/29/2014)...   Vittamed Corporation , a neurodiagnostics medical device company ... T. (Teo) Forcht Dagi , MD, DmedSc, MPH, MBA, ... " Teo Forcht Dagi is an ... and venture capital," said Remis Bistras , President and ... clinical, strategic, and entrepreneurial expertise to our Board." ...
Breaking Medicine Technology:Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2
... YORK, April 23, 2012  Delcath Systems, Inc. (NASDAQ: ... working capital line of credit revolver with Silicon Valley Bank ... sciences. The credit facility is available for general corporate purposes ... Commenting on the transaction, Eamonn P. Hobbs, President ...
... 21, 2012 Medaxial, the healthcare value ... Queen,s Award for Enterprise in recognition of its international ... are the UK,s most prestigious business accolade, bestowed by ... of companies who have achieved outstanding results in international ...
Cached Medicine Technology:Delcath Systems, Inc. Secures $20 Million Credit Facility 2Delcath Systems, Inc. Secures $20 Million Credit Facility 3Delcath Systems, Inc. Secures $20 Million Credit Facility 4Pharmaceutical Industry Service Company Awarded The UK's Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade 2Pharmaceutical Industry Service Company Awarded The UK's Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade 3
4.625 inches, curved blade 4 mm....
Walton foreign body gouge 4 1/2 inches, round end....
... made from MMA/VP material and has a high ... supplied with the base curve and total diameter ... available in a power range of -30.00DS to ... protective and therapeutic applications including the controlled on-eye ...
... premium high water content ... permeability. Standard one fit ... the following therapeutic conditions: ... bullous keratopathy, recurrent ulcers, ...
Medicine Products: